New Immune Marker Research on Ketamine for Treatment-Resistant Depression (2026 Study)

IL-15 and IL-7: the immune markers a new 2026 study looked at beyond the standard inflammation markers (CRP and IL-6), and how they tracked with ketamine response in depression.